Bacterial Vaginosis Market to Grow at a CAGR of 9.2% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Bacterial Vaginosis Market Size During 2025–2029?

The bacterial vaginosis market size has witnessed substantial growth in recent years. This market is forecast to expand from $3.03 billion in 2024 to $3.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.3%. Historically, this growth can be attributed to several factors including the rising adoption of point-of-care diagnostics, the expansion of e-commerce, an increase in risky sexual behaviors, a surge in STI vaccination efforts, and improved access to healthcare.

The bacterial vaginosis market size is projected to exhibit robust expansion in the coming years, with expectations to reach $4.71 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period can be linked to the increasing occurrence of bacterial vaginosis, a surging demand for functional foods, a rise in the incidence of STIs, a growing prevalence of women’s health conditions, and enhanced awareness of menopause. Significant trends for this period encompass the incorporation of artificial intelligence (AI) in diagnostic methods, the greater adoption of probiotics, improvements in home-based STI testing, and the utilization of sustainable materials in women’s health devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

Which Factors And Drivers Are Influencing The Bacterial Vaginosis Market In 2025?

The escalating occurrence of sexually transmitted infections (STIs) is anticipated to propel the expansion of the bacterial vaginosis market. Sexually transmitted infections (STIs) are conditions predominantly transmitted via sexual contact, stemming from bacteria, viruses, or parasites. The rise in STI cases is attributable to elements such as unsafe sexual practices, numerous partners, insufficient public knowledge, and drug resistance. Bacterial vaginosis enhances vulnerability to STIs by disturbing the natural balance of vaginal bacteria, thus facilitating the establishment of infections like HIV and chlamydia. For instance, in March 2024, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2022, there was a significant increase in reported cases compared to the previous year, with gonorrhea rising by 48%, syphilis by 34%, and chlamydia by 16%. Consequently, the growing frequency of sexually transmitted infections (STIs) is fueling the advancement of the bacterial vaginosis market.

What Are The Segment Types Shaping The Bacterial Vaginosis Market?

The bacterial vaginosismarket covered in this report is segmented –

1) By Type: Point-Of-Care Testing; Laboratory Testing; Other Types

2) By Product: Below 15 Years; Between 15-45; Other Products

3) By Application: Antibiotics; Other Applications

4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests; Microscopy-based Tests; Immunoassays

2) By Laboratory Testing: Gram Staining; Polymerase Chain Reaction (PCR); DNA Probe Tests; Culture-based Testing

3) By Other Types: Home Testing Kits; Enzyme-linked Immunosorbent Assay (ELISA)

How Are Emerging Market Trends Shaping The Bacterial Vaginosis Industry Landscape?

Major companies within the bacterial vaginosis market are concentrating on creating advanced solutions, including multiplexed polymerase chain reaction (PCR) tests, to accelerate diagnosis and treatment. Such a test is a form of polymerase chain reaction (PCR) analysis designed to enable the concurrent amplification and identification of several target DNA or RNA sequences within one PCR procedure. As an illustration, in November 2022, Cepheid, a US-based biotechnology research company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This panel delivers swift outcomes in under 60 minutes, identifying three vaginal infections—bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV)—from just one sample. It accommodates both clinician-collected and self-collected swabs, utilizing automated real-time PCR technology to boost diagnostic precision and improve treatment results for women. Its adaptable nature facilitates its application across diverse clinical environments, guaranteeing effective and accurate detection of vaginal infections.

Which Leading Players Are Enhancing Their Bacterial Vaginosis Market Presence Worldwide?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Which Regional Markets Are Contributing Most To The Bacterial Vaginosis Industry Expansion?

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Bacterial Vaginosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2025, By The Business Research Company

Vaginal Sling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

Vaginitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaginitis-therapeutics-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795